Lara N Traeger
Overview
Explore the profile of Lara N Traeger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
414
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gikandi A, Hallet J, Groot Koerkamp B, Clark C, Lillemoe K, Narayan R, et al.
Ann Surg
. 2024 Feb;
279(6):907-912.
PMID: 38390761
Objective: To determine the prevalence of clinical significance reporting in contemporary comparative effectiveness research (CER). Background: In CER, a statistically significant difference between study groups may or may not be...
2.
Finkelstein-Fox L, Bliss C, Rasmussen A, Hall D, El-Jawahri A, Perez G, et al.
Support Care Cancer
. 2023 Oct;
31(10):616.
PMID: 37801182
Purpose: Cancer "curvivors" (completed initial curative intent treatment with surgery, radiation, chemotherapy, and/or other novel therapies) and "metavivors" (living with metastatic or chronic, incurable cancer) experience unique stressors, but it...
3.
Amonoo H, Deary E, Wang A, Newcomb R, Daskalakis E, Weber D, et al.
Transplant Cell Ther
. 2023 Jul;
29(10):620.e1-620.e11.
PMID: 37516379
Medication adherence is critical for optimal health outcomes in patients with hematologic malignancies who have undergone allogeneic hematopoietic stem cell transplants (HSCT). However, this population struggles with medication nonadherence. Research...
4.
Amonoo H, Daskalakis E, Deary E, Celano C, Ghanime P, Healy B, et al.
Contemp Clin Trials
. 2023 Jun;
131:107272.
PMID: 37380022
Background: Although patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) experience low levels of positive psychological well-being (PPWB), interventions that specifically boost PPWB in this population are lacking. Objective: To...
5.
Petrillo L, Shimer S, Zhou A, Sommer R, Feldman J, Hsu K, et al.
Cancer
. 2022 Jun;
128(16):3120-3128.
PMID: 35731234
Background: Although most patients with cancer prefer to know their prognosis, prognostic communication between oncologists and patients is often insufficient. Targeted therapies for lung cancer improve survival yet are not...
6.
Fong Z, Traeger L, Chang D
J Clin Oncol
. 2022 Jun;
40(25):2997-2998.
PMID: 35671417
No abstract available.
7.
Yin and Yang of Psychological Health in the Cancer Experience: Does Positive Psychology Have a Role?
Amonoo H, El-Jawahri A, Deary E, Traeger L, Cutler C, Antin J, et al.
J Clin Oncol
. 2022 Apr;
40(22):2402-2407.
PMID: 35377731
No abstract available.
8.
Shalev D, Traeger L, Doyle K, Kiser S, Brenner K, Rosenberg L, et al.
J Palliat Med
. 2022 Jan;
25(3):349-354.
PMID: 35085468
This is the seventh entry in the (PEPC) series. Previous articles have focused on the psychological elements of the care we provide patients and the relationships we build with our...
9.
Amonoo H, LeBlanc T, Kavanaugh A, Webb J, Traeger L, Jagielo A, et al.
Cancer
. 2021 Mar;
127(14):2500-2506.
PMID: 33764526
Background: Patients with acute myeloid leukemia (AML) receiving intensive chemotherapy face a life-threatening illness, isolating hospitalization, and substantial physical and psychological symptoms. However, data are limited regarding risk factors of...
10.
Petrillo L, Traeger L, Sommer R, Zhou A, Temel J, Greer J
J Cancer Surviv
. 2021 Mar;
15(3):386-391.
PMID: 33686611
Purpose: Molecularly targeted therapies have revolutionized non-small cell lung cancer (NSCLC) treatment. Many patients with metastatic NSCLC receiving targeted therapy may live several years with incurable cancer. We sought to...